Related Experiment Video
Updated: Jul 8, 2026
11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Lead hepatotoxicity & potential health effects.
1National Center for Environmental Assessment, Office of Research & Development, U.S. EPA, North Carolina 27709, USA. Mudipalli.anu@epa.gov
The Indian Journal of Medical Research
|January 26, 2008
Summary
Lead (Pb) exposure poses global health risks, primarily affecting the gastrointestinal system and liver. Research explores Pb
Area of Science:
- Environmental Toxicology
- Occupational Health
- Hepatology
Background:
- Lead (Pb) is a toxic metal pollutant with widespread occupational and environmental exposure.
- Exposure routes include inhalation and ingestion, with Pb accumulating in soft tissues and bone, notably the liver.
- High Pb concentrations cause neuronal encephalopathy, while lower levels (30-80 microg/dl) manifest as gastrointestinal distress.
Purpose of the Study:
- To review the toxicological effects of lead (Pb) on the liver and potential extrahepatic damage.
- To explore the biochemical and molecular mechanisms of Pb-induced hepatotoxicity.
- To discuss chelation therapy for Pb-induced liver damage.
Main Methods:
- Literature review of occupational and environmental lead (Pb) exposure.
- Analysis of autopsy studies on Pb-exposed patients.
- Examination of animal toxicology studies on Pb effects.
- Review of research on molecular aspects of Pb toxicology.
Main Results:
- Lead (Pb) significantly accumulates in the liver (approx. 33% of soft tissue Pb).
- Pb exposure is linked to gastrointestinal colic and hepatotoxic effects.
- Molecular studies reveal Pb impacts hepatic enzymes, cholesterol metabolism, oxidative stress, and hepatic hyperplasia.
- Pb may damage extrahepatic systems, including the cardiovascular system.
Conclusions:
- Lead (Pb) exposure is a significant cause of liver damage and may affect other organs.
- Understanding Pb's molecular toxicology is crucial for assessing broader health impacts.
- Chelation therapy shows potential for treating Pb-induced hepatotoxicity.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...